Brian Tyler, currently President and Chief Operating Officer (COO) of McKesson Corporation and Chairman of the Supervisory Board of McKesson Europe, has been unanimously elected by McKesson's Board of Directors to succeed Hammergren as Chief Executive Officer (CEO) effective April 1, 2019.
It has been an honour to serve as McKesson’s CEO for nearly 20 years. This is the right time to turn the leadership reins over to the next generation and no one is better equipped than Brian to lead McKesson into the future.John H. Hammergren, Chairman and CEO, McKesson Corporation
Tyler has been with the company for 21 years. During this time, he has led nearly every major business unit within the company, as well as McKesson’s corporate strategy and business development unit. From April 2017 to July 2018, he was Chairman of the Management Board (CEO) of McKesson Europe, where he focused the company on operational excellence, collaboration and innovation. Previously, Tyler served as President of McKesson North American Pharmaceutical Distribution and Services, McKesson U.S. Pharmaceutical, McKesson Medical-Surgical and McKesson Specialty Health, as well as Executive Vice President of corporate strategy and business development.
Edward Mueller, currently Lead Independent Director on McKesson’s Board of Directors, will succeed Hammergren as an independent Chairman of the Board, also effective April 1, 2019. He has been a Director at McKesson since April 2008 and has served as the Lead Independent Director since July 2013.
Ed Mueller will be a terrific Chairman of our Board of Directors. During his 10 years of service on our Board, Ed has developed a deep knowledge of McKesson and our industry. He has the respect of our board, McKesson’s leaders and our investors.John H. Hammergren, Chairman and CEO, McKesson Corporation
Further information can be found in our press release.